D
DaVita Clinical Research DCT RDN | InterMed Consultants, Ltd.
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
VX-147
Finerenone
Zanubrutinib
KBP-5074
Parent organization
This site is a part of DaVita Clinical Research DCT RDN
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 4 total trials
The primary objectives of this study are: In Part 1 to evaluate the efficacy of zanubrutinib as measured by proteinuria reduction, and in Part 2 to e...
Enrolling
Primary Membranous Nephropathy
Drug: Tacrolimus
Drug: Zanubrutinib
Researchers are looking for a better way to treat people who have non-diabetic chronic kidney disease (non-diabetic CKD). The trial treatment, finere...
Active, not recruiting
Non-diabetic Chronic Kidney Disease
Drug: Finerenone (BAY94-8862)
Drug: Placebo
The purpose of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants...
Enrolling
Proteinuric Kidney Disease
Drug: Placebo
Drug: VX-147
Trial sponsors
K
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems